Analysis of pharmaceutical solids using solid‐state
nuclear magnetic resonance
(
NMR
) spectroscopy is finally coming of age. The wealth of information that solid‐state
NMR
can provide is unmatched by any other single technique used to characterize pharmaceutical solids. Perhaps the area where
NMR
can provide the most benefit to pharmaceutical scientists is in the analysis of formulated drug products, where the
active pharmaceutical ingredient
(
API
) is diluted in the presence of one or more inactive ingredients, or excipients. Unlike most other techniques,
NMR
has the ability to selectively characterize the physical states of the
API
as well as excipients, as they exist together within the formulation, without separation or sample destruction. Critical issues such as crystal form, crystallinity, amorphous content, ionization states, hydration states, molecular mobility, and drug–excipient interactions may all be studied using modern solid‐state
NMR
. Here we examine some of the presently available literature, provide relevant references, and demonstrate examples of how to best utilize the technique and interpret the results.